Sir Peter Dixon (Chair)
Sir Peter Dixon took up the post of Chair of Diabetes UK on 1 January 2013. He brings to the charity a depth of senior-level experience with the NHS and other public bodies. For ten years he served as a Council Member and Trustee for the NHS Confederation, the membership body for all organisations that commission and provide NHS services. He has also been Chair of University College London Hospitals NHS Foundation Trust and the Enfield and Haringey Health Authority.
Peter is currently Chair of Imperial College Health Partners and also a trustee of Pathway, the UK’s leading homeless healthcare charity. Peter has been a board member in registered social landlords for nearly 40 years and was Chair of the Housing Corporation, the Government’s national affordable housing agency, from October 2003 until December 2008. He was knighted for services to housing in 2009.In his earlier career, Peter held a number of roles in business, banking, and corporate finance. He is a graduate of Corpus Christi College, Cambridge, and holds a Masters degree in Modern History and an MSc in Business Studies from London Business School.
Janice Watson (Vice-Chair)
Janice became a Trustee of Diabetes UK in January 2015. She first became involved with Diabetes UK when her son developed Type 1 diabetes in 2010. Her father-in-law also has Type 2 diabetes, giving her personal experience of the challenges of managing both conditions in day to day life.
Janice brings considerable senior financial experience to her role as Trustee. She is a professional treasurer, with over 25 years’ experience in this field, and is currently employed in the financial services sector. She has both current and previous experience as a pensions’ Trustee and sat on the Advisory Investment Committee of WHO from 2006 to 2015. Her early working life was spent teaching English in Sudan, the UAE and Egypt.
In her spare time, she enjoys walking her dog in the Chilterns, where she now lives, and relaxing through yoga practice.
Professor Sir Harry Burns
Sir Harry Burns graduated in medicine from Glasgow University in 1974. He trained in surgery in Glasgow and he was appointed as a Consultant Surgeon and in the University Department of Surgery at the Royal Infirmary in Glasgow in 1984. Working with patients in the east end of Glasgow gave him an insight into the complex inter-relationships between social and economic status and illness. He completed a Masters Degree in Public Health in 1990 and shortly afterwards was appointed Medical Director of The Royal Infirmary.
In 1994, he became Director of Public Health for Greater Glasgow Health Board, a position he occupied until 2005. During his time with Greater Glasgow Health Board he continued research into the problems of social determinants of health and in 2005, he became Chief Medical Officer for Scotland. In this role, his responsibilities included aspects of public health policy, health protection and, for a time, sport.
He was knighted in 2011 and in April 2014, he became Professor of Global Public Health at Strathclyde University where he continues his interest in understanding how societies create wellness. In 2014, the First Minister, Nicola Sturgeon, presented him a lifetime achievement award from the Scottish Government and the Scottish Parliament for Public Service.
Rosie was appointed a Trustee in July 2017. She has 25 years of executive experience holding senior positions in the pharmaceutical and medical technology industry, primarily focusing on the European and North American markets. She has led and driven the development of both large globally listed companies and small newly established VC backed investments. Over the past 10 years, Rosie has specialised in leading early stage technology companies through critical growth stages to become leading market disrupters.
She has been the CEO of Nasdaq listed Episurf Medical AB, CEO of UK-based ToHealth Ltd., interim CEO of FreeHand 2010 Ltd. and European President & General Manager of Galil Medical. Prior to that, she was UK Sales and Marketing Director for NYSE listed CR Bard. Rosie has also held several key commercial positions at FTSE listed Smiths Industries within the medical division. Rosie earned a pharmacy degree from the University of the Sciences in Philadelphia and studied business management at the University of Pennsylvania.
Rosie is on the Commercial Advisory Board of Iseo Digital Health, is a subject matter expert for OurMobileHealth and a digital health mentor for StartUpBootcamp Berlin. She is also a trustee of Horder Healthcare.
For fun, Rosie likes to play sport, cook and biohack her own health data to prevent disease. She is passionate about supporting and educating people with diabetes and has two young type 1 diabetes family members.
Professor Wasim Hanif
Wasim is a Professor of Diabetes & Endocrinology, Consultant Physician, and Clinical Director in Diabetes at University Hospital Birmingham. He is an eminent authority on diabetes, obesity, and ethnic health and works with several national bodies, and professional groups in the UK.
He has been involved with major research projects in diabetes and has published widely. He was selected for Kings Fund Leadership Programme in Diabetes. His research interest includes: diabetic kidney disease, diabetes prevention, management of diabetes in Ramadan, obesity, ethnicity and tackling health inequalities. He is involved as a chief and principal investigator in several international multi-centre trials and was instrumental in setting up UKADS (United Kingdom Asian Diabetes Study).
Wasim has been involved at a parliamentary level to advise the government on issues relating to Diabetes and ethnic health. He is the Chair of the Diabetes Working Group of the world-recognised South Asian Health Foundation (SAHF). Wasim is a member of the Parliamentary and Stakeholder Diabetes Think Tank advising the All Party Parliamentary Group on Diabetes.
His involvement in NICE has been extensive, sitting on advisory NICE Health Technology Appraisal Committee since 2009, and acting as an advisor on many issues including the use of health technologies, definitions of Obesity and Waist circumference in British South Asians, prevention of diabetes in high risk groups, physical activity and type 2 diabetes.
He is on the Expert Advisory Committee of Commission of Human Medicine, advising MHRA on new Medicinal agents. He is on the Board of Governors as a Trustee of Diabetes UK, helping in strategy, advocacy, patient empowerment and research to help improve outcomes in people with diabetes in the UK.
He holds the qualifications MBBS MD FRCP.
Gareth brings over 30 years of professional and executive commercial experience gained both in the UK and internationally.
Gareth served as an Executive Director of Legal & General plc, where he worked for 19 years, holding executive positions in Legal & General’s UK insurance, corporate and retail savings businesses. As well as the Legal & General Main Board, he served on the board of its UK operating company, Legal & General Assurance Society Ltd, and on the boards of its General Insurance, Group Risk, Unit Trust and Banking businesses. As CEO of Legal & General’s International Division, he served on the boards of all its major international subsidiaries and also its joint ventures across North America, Europe, the Middle East, Egypt and India. He served as Trustee on the boards of Legal & General’s Group pension schemes.
After graduating, he joined Price Waterhouse where he qualified as a Chartered Accountant and worked for 10 years in both in their London and Australian offices. Gareth is an advisor to Green Park Partners Ltd, an investment and advisory business based in London
In addition to extensive financial expertise Gareth brings considerable commercial experience of business strategy, starting and growing companies and running large complex organisations. His passion and commitment to serve Diabetes UK is driven by his first-hand experience of supporting both Type 1 and Type 2 diabetic members of his immediate family.
Ian was appointed as a Trustee in July 2017. He is currently Head of Equities for Tesco Pension Investment, which manages the assets of the Tesco plc pension scheme, containing the retirement savings of over 350,000 current and past employees of the company. He has spent a substantial part of his thirty years in investment following the global healthcare sector, covering pharmaceutical companies and device manufacturers, as well as many other areas of this industry.
Ian was diagnosed with Type 1 diabetes in 1995 and has two close family members with Type 2 diabetes. He has supported the charity for many years, raising money through running charity quizzes, running a half marathon and jumping out of an aeroplane. This is in addition to his senior role at Tesco, which has been a significant corporate supporter of Diabetes UK. Ian has a degree in French and Russian from Brasenose College, Oxford and also is a CFA charter holder (Chartered Financial Analyst). In his spare time he enjoys cycling, skiing, watching his sons play rugby and quizzes.
Helen retired as Director General of Consumers International in December 2013. Her role involved lobbying for consumer rights at international level and helping to build consumer protection in parts of the world where it is weak.
She spent the majority of her previous career in senior roles which involved helping large organisations to understand and meet the needs of their users and customers. She was Head of Communications for the NHS for five years before being appointed the first Director of Communications for the Department of Health in 1999. From there she spent seven years as Director of Corporate Affairs for the UK Environment Agency.
Helen brings considerable experience of campaigning on health and related issues, of listening and responding to the public, and a knowledge of the charity sector. She was a trustee of Keep Britain Tidy for six years from 2005–10, and is now also a trustee of "Arts and Minds", a charity based in Cambridgeshire devoted to providing arts services for people with mental health problems.
Helen lives in Cambridge – she is an amateur actor and director, helps to look after her three grandchildren and enjoys walking, swimming and skiing.
Robin Swindell, known to his friends as Bob, is an experienced reinsurance practitioner who writes about the mutual insurance sector, reinsurance, running and diabetes.
He was diagnosed with Type 2 Diabetes in May 2013, and manages the condition with diet, exercise and oral medication. He is a keen runner, occasional cyclist and can usually be found at Oak Hill parkrun at 9 o’clock on Saturday morning.
He is one of parkrun's Diabetes Champions and joined the board in July 2017.
He tweets as @fractis.
Professor Thomson is the incoming Vice Chancellor of the University of London. She is an independent member of the University of East Anglia and the Norwich University of the Arts.
Professor Thomson was Managing Director of Norfolk County Council until the end of 2018. Previously she was Chief Executive of the London Borough of Newham, and former Prime Minister Blair’s adviser on Public Service Reform a role for which she received her CBE in 2005.
Wendy has worked on government reform with heads of state in Nigeria, Ghana and with the UNDP. Before joining Norfolk for ten years Wendy was Professor of Social Policy and Director of the School of Social Work at McGill University in Montreal, Canada.
She lives in Norwich with her teenage daughter, and is a keen tennis player, walker and regular yoga practitioner.
Dr Bob Young
Bob brings to the Board the perspective of more than 25 years as a Consultant Diabetologist. During his time at Salford Royal NHS Foundation Trust (Acute and Community) he has had sub-specialty interests in children & young people’s diabetes, diabetic pregnancy, inpatient diabetes and diabetic complications. He chairs the local diabetes network steering group Salford Diabetes Care, is clinical lead of the South Manchester Diabetic Retinopathy Screening Programme and was for ten years Trust Director of Clinical Effectiveness and Clinical Information Technology. He has published more than 100 research papers on the pathogenesis and treatment of diabetic neuropathy/foot disease and IT applications to improve the quality of clinical care.
Bob served on the St Vincent Task Force, the Diabetes NSF external reference group, the GMC performance assessment development programme and has chaired the RCP specialty sub-committee for Diabetes and Endocrinology. Since its inception in 2003 he has been Clinical Lead for the National Diabetes Audit (NDA) and he is foundation clinical lead of the National Diabetes Information Service (NDIS).
Bob graduated from Dundee University in 1976, did postgraduate studies in Edinburgh and holds the degrees of MBChB, MMSc, MD, FRCP. He was awarded CBE for services to medicine and healthcare 2010.